Migfilin, a protein component of focal adhesions, has been implicated in regulation of cell-extracellular matrix adhesion and motility but the underlying mechanisms are not fully elucidated. In this study, we have determined the functions of migfilin in esophageal cancer cells and the mechanisms involved. We demonstrate that the expression level of migfilin is negatively associated with clinical metastasis, and enforced expression of migfilin suppressed cell motility through decreased free β-catenin level. Overexpression of migfilin resulted in destabilization of β-catenin in concomitance with reduction of its transcriptional activity. Knockdown of migfilin by siRNA, transfection of a mutant β-catenin at Ser37 which is a critical phosphorylation site of GSK3β, GSK3β inhibitor LiCl or proteasome inhibitor MG132 reversed the migfilin-mediated β-catenin degradation and transcription inhibition. Moreover, migfilin promoted β-catenin degradation by reinforcing the association between β-catenin and GSK3β.
Introduction
Tumor metastasis is a multistep process involving decreased cellular adhesion, degradation of the extracellular matrix, and colonization of a distant site (1) . These discrete steps associate with a series of signal cascade, while specificity in signaling could be achieved by specific complex formation and subcellular translocation. β-catenin is such a multifunction protein which plays a critical role in embryonic development and tumorigenesis through its effects on E-cadherin-mediated cell adhesion and Wnt-dependent signal transduction (2, 3) . And these mutually exclusive interactions control its subcellular distribution (4) . β-catenin dominantly localizes at the membrane and interacts with cytoplasmic region of E-cadherin, linking the cadherin-mediated cell-cell contacts to the actin cytoskeleton, while the cytoplasm abundance and nuclear location of β-catenin is controlled by a multicomponent destruction complex containing GSK-3β, axin and APC (5) . These proteins initiate the amino-terminal S/T phosphorylation, and thereby target β-catenin to ubiquitination and proteasome degradation (6) . Loss of control of intracellular β-catenin levels through Wnt signaling results in its stabilization and accumulation in the cytoplasm. The resulting increased free β-catenin promotes its nuclear translocation and the formation of transcriptionally active complexes with members of the TCF/LEF family, stimulates the transcription of specific genes which are involved in oncogenic transformation (3) PI3K/Akt signaling stimulated by IGF-1 or EGFR has also been shown to inactivate GSK-3β through phosphorylation at Ser9, which leads to increase of β-catenin availability as a transcriptional activator (7, 8) . Akt can also directly phosphorylate β-catenin at Ser552, cause its disassociation from cell-cell contacts and enhance its transcriptional activity (9) , the mechanism mentioned above are all involved in promoting tumor angiogenesis and metastasis.
Migfilin, a member of the zyxin famlily, was identified from yeast two-hybrid genetic screen using kindlin-2 (also known as mitogen-inducible gene 2 or mig-2), a component of cell-ECM adhesions (10) , as bait. Migfilin is an adaptor protein consisting of three structurally distinct regions, including an N-terminal filamin-binding domain, a central proline-rich domain which contains a NES, and a kindlin-2-binding C-terminal LIM region (10) (11) (12) (13) . Previous reports showed that migfilin links cell-matrix adhesions to the actin cytoskeleton and regulates cell morphology and motility (10, (13) (14) (15) (16) (17) . It has been also implicated in regulation of anoikis in untransformed epithelial cells (18) . In addition, migfilin induces differentiation of cardiomyocyte through transporting to nucleus and promoting CSX/NKX2-5-induced gene expression (11) . It has been shown that increased cytoplasmic level of migfilin is associated with higher grades of leimyosarcomas (19) , but its expression and function in other types of tumor and downstream signaling events remain unclear. The LIM protein FHL2 has been documented to enhance β-catenin transcription through promoting β-catenin acetylation (20) , whereas another LIM protein 7 (Biochrom), while HEK293T cells were maintained in DMEM (Invitrogen) with 10% FBS. Lipofectin 2000 (Invitrogen) was used for plasmid transfection while Hiperfect (Qiagen) was used for the siRNA transfection according to the manufacturers' protocols, and the cells were analyzed 2 days after the transfection. In the stable transfection, migfilin over-expression clones were selected by G-418 sulfate (Invitrogen).
Antibodies
Monoclonal anti-migfilin Ab (clone 43) was described previously (10) .
Antibodies against β-catenin (Santa Cruz), p-β-catenin, GSK3β (Cell Signaling), and FLAG, β-actin (Sigma) were also used.
Tissue specimens
Fresh tissue specimens were taken from patients presented at the First Affiliated Hospital of Anhui Medical University (Anhui province, China) immediately after surgery and stored at -80°C until use. None of the patients had received radio-or chemo-therapy before surgery. 
Immunoprecipitation
For immunoprecipitation analysis, the transfectants were lysed with the lysis buffer (1% Triton X-100 in 50 mM Tris-HCl, pH 7.4, containing 150 mM NaCl, 5mM EDTA, PH 7.4, 2 mM Na3VO4, 100mM NaF), and supplemented with a cocktail of protease inhibitors (Sigma). Total protein (2mg) was incubated with different antibodies as indicated overnight at 4°C. The IgG derived from the same species as the primary antibody was used as the negative control. After incubation of lysates with protein A/G agarose beads (Abmart) for 2 hours at 4°C, the beads were washed four times and the immunoprecipitates were analyzed by Western blotting with antibodies as specified.
Migration and invasion assay
Cell migration and invasion ability was analyzed using Transwell motility chambers as previously described (23). Briefly, the undersurfaces of the 8-μm pore diameter Transwell motility chambers (Corning) were precoated with or without 30 μg Matrigel (BD Biosciences). 15×10 6 cells in serum-free culture medium were plated into the upper chamber and the lower chamber was filled with medium containing 10% FBS. After incubation at 37°C for 24 h, cells remain on the upper surface of the compartment were removed, and the inserts were fixed with methyl alcohol and stained with crystal violet solution (0.5%). The cells from 3 randomly selected microscopic fields were counted. The results were averaged among three independent experiments.
Luciferase reporter assay
The cells of 90% confluence in 96-well plates were transfected by using Lipofection 2000 (Invitrogen) with a variety of constructs as specific in each experiment and 0.5ng pRL-SV40 Renilla construct (Promega) as an internal control to normalize luciferase activity for transfection efficiency. After 48 hours, luciferase activity was measured using a dual luciferase reporter assay system (Promega) according to the manufacturer's instructions. For each plasmid construct, three independent transfection experiments were performed.
Western blot analysis
Proteins were separated by SDS-PAGE, transferred to PVDF membranes (Amersham Bioscience), blocked with milk, and then probed with antibodies as indicated. Protein bands were detected by chemiluminescence using the ECL system (Vigorous) according to the manufacture's protocol.
Real time quantitative PCR
Migfilin mRNA was measured using the ABI Prism 7300 sequence detection system (Applied Biosystems) as previously described (25). The Fig. S1 ).
Migfilin suppresses esophageal cancer cell migration and invasion
To gain insight into the effect of migfilin on the motility potential of esophageal cancer cells, we overexpressed migfilin in KYSE450 cells which showed nearly undetectable migfilin expression and silenced migfilin in KYSE150 cells with moderate inherent migfilin expression ( Supplementary Fig.   S2 ). Clones with stable ectopic migfilin overexpression (T1, T2) or the vector control (K1, K2) ( Fig. 2A ) from KYSE450 cells were selected and analyzed using cell migration and Matrigel invasion assays. The results showed that overexpression of migfilin significantly attenuated KYSE450 esophageal cancer cell migration and invasion (Fig. 2C) . To further test this, we knockdown of migfilin in KYSE150 cells with two distinct migfiin-specific siRNAs (seq1 and seq2) and the results showed that knockdown of migfilin potently promoted cell migration as well as invasion ( Fig. 2B and 2D) . These results indicate a suppressive role of migfilin in esophageal cancer cell migration and invasion.
Migfilin inactivates β-catenin-mediated transcription
We next explored which signaling pathway is involved in migfilin-mediated suppression of cell invasion and migration. Since it has been reported that migfilin links focal adhesion with cytoskeleton (10) and regulates cell-cell contact formation (12), we proposed that overexpression of migfilin impaired cell motility may attribute to the alteration of cell morphology and adhesion.
Therefore, we analyzed a series of molecules responsible for orchestration of adhesion structures and found that only endogenous β-catenin was significantly decreased in the migfilin stable transfecants T1 and T2 (Fig. 3A) while other cell adhesion proteins, such as integrin-β1 and E-cadherin remained unaltered (data not shown).
To test whether migfilin-mediated down-regulation of β-catenin could result and 4D, treatment with LiCl or MG132 abolished migfilin-induced downregulation of β-catenin. To be convinced, we also used another specific GSK3β inhibitor SB415286, which showed the similar effect with LiCl ( Supplementary Fig. S4 ). These results implicated that GSK3β activity and proteasomal degradation system are involved in migfilin-mediated destabilization of β-catenin.
Migfilin interacts with β-catenin and promotes GSK3β-mediated β-catenin phosphorylation
Since GSK3β activity is required for migfilin-induced reduction of β-catenin, and it has been reported that migflin co-localized with β-catenin at cell-cell adhesions and knockdown of migfilin by siRNA disturbed the organization of adhesion junction (12), we hypothesize that migfilin associates with β-catenin and promotes its phosphorylation by GSK3β.
To test this, we first investigated whether migfilin associates with β-catenin. We expressed a constitutive β-catenin and FLAG-migfilin into HEK293T cells, and immunoprecipitated migfilin with the FLAG antibody. Immunoblotting analysis showed that β-catenin was co-immunoprecipitated with migfilin, but not with the control immunoglobulin precipitates (Fig. 5A ). Reciprocally, migfilin was found in the immunoprecipitates obtained with anti-β-catenin antibody (Fig.   5A ). In concordance with the above results, endogenous migfilin binds β-catenin and vice versa (Fig. 5A ). These results confirm that migfilin associates with β-catenin. Next, we exogenously expressed migfilin and β-catenin in HEK293T cells and examined the effect of migfilin expression on GSK3β-mediated phosphorylation of β-catenin. The level of phosphorylated β-catenin was determined by immunoblotting with a phosphor-S33/S37/T41 β-catenin-specific antibody (26). In the presence of migfilin, the degree of phosphorylated β-catenin was enhanced when the equivalent amounts of β-catenin were immunoprecipitated from the lysates of both control and migfilin overexpression cells (Fig. 5B) . Similar results were also obtained using KYSE450 stable clones (Fig. 5C) . Furthermore, the association of GSK3β with β-catenin was enhanced in response to increased expression of migfilin in a dose-dependent manner (Fig. 5D ). To further confirm the participation of GSK3β in migfilin-mediated regulation of β-catenin, we generated a construct encoding S37A β-catenin, which is a β-catenin mutant relatively insusceptible to phosphorylation by GSK3β and subsequently proteasomal degradation (21) .
We transfected wild-type and S37A β-catenin along with TOPFLASH into HEK293T cells, respectively. Luciferase activity assay showed that migfilin efficiently attenuates the transcriptional activation of wild-type β-catenin, but had no appreciable effect on the S37A β-catenin-induced TOPFLASH activity (Fig. 5E ). These data clearly demonstrated that GSK3β-mediated phosphorylation of β-catenin was facilitated by migfilin and GSK3β is involved in migfilin-mediated degradation of β-catenin.
Migfilin regulates cell motility through β-catenin
Previous studies suggest that β-catenin is associated with tumor progression and metastasis (27-30). To examine whether β-catenin degradation is involved in migfilin-mediated inhibition of cell motility, we transfected cells that stably overexpress migfilin with a plasmid encoding FLAG-β-catenin. Overexpression of FLAG-β-catenin was confirmed by Western blotting (Fig. 6B) . Forced transient β-catenin overexpression partially restored cell invasion (Fig. 6A) . However, cell migration remained invariable despite ectopic expression of FLAG-β-catenin (data not shown), implicating that other protein kinases or signaling pathways may also be involved in migfilin-mediated regulation of cell motility. These data suggested that 
mechanism involved has not been explored. In the current study, we show that overexpression of migfilin inhibits cell invasion partially through degrading β-catenin in the cytoplasm or repressing its transcription activity in the nucleus.
We also silenced migfilin by siRNA and found that down-regulation of migfilin increased β-catenin and augmentation in TCF activity It has been reported that migfilin can interact with kindlin-2 to participate in cell shape modulation and cytoskeleton rearrangement (10) . Migfilin is also known to compete with integrin β1 cytoplasmic tails to bind with actin-linking protein filamin A, which indirectly results in integrin activation (14) (15) (16) . Besides, migfilin has been documented to bind VASP and inhibit cell migration (17) Unfortunately, we are unable to determine whether migfilin binds β-catenin directly or mediated by other proteins as well as the domains responsible for the interaction, and these need to be further investigated.
Because overexpression of migfilin resulted in reduction of β-catenin, it was conceivable that overexpression of migfilin would inhibit the Wnt pathway by decreasing the availability of free β-catenin. However, in KYSE450 cells, it was not the case; very low levels of β-catenin transactivating activity were detected in the KYSE450 cells and we found no significant differences in β-catenin signaling through other pathways in a fashion that is independent of its ability to promote TCF-induced transcription, so the expression of migfilin induced degradation of β-catenin did not affect it transcriptional activity in an apparent way ( Supplementary Fig. S3 ). Therefore we speculate that inhibition of the Wnt pathway is not the mechanism for migfilin induced suppression of cell motility in KYSE450 cells and there may be other mechanism(s) involved. To clarify the biological significance of migfilin promoted β-catenin degradation, we have used other two esophageal cancer cells KYSE30 and KYSE180 whose endogenous migfilin protein expression level was similar with KYSE450
( Supplementary Fig. S2 ), and the result showed that overexpression of migfilin in the two esophageal cancer cells suppressed the transcriptional activity of endogenous β-catenin (Supplementary Fig. S3 ). Taken The results were the means of three independent experiments ± SD (right); *, P < 0.05. 
